AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION: Form 990, tax year 2019
View the entire original 990 at ProPublica ↗
- Organization
- AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION (EIN 23-7033369)
- Tax period
- 2019-06-01 to 2020-05-31
- Filed
- 2021-03-19
- IRS object ID
- 202100789349300900
- Schema version
- 2019v5.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2021-03-19T08:05:26-05:00 | ReturnTs |
| Tax Period End | 2020-05-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 420714325 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RSM US LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2021 L STREET NW SUITE 400 | AddressLine1Txt |
| City | WASHINGTON | CityNm |
| State Abbreviation | DC | StateAbbreviationCd |
| ZIP | 20036 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2019-06-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 237033369 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMERICAN SOCIETY OF HEALTH-SYSTEM | BusinessNameLine1Txt |
| Business Name Line2 | PHARMACISTS RESEARCH AND EDUCATION FDTN | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | AMER | BusinessNameControlTxt |
| Phone | 3016648612 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4500 EAST-WEST HIGHWAY NO 900 | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | STEVEN RUBLOFF | PersonNm |
| Person Title | SECRETARY AND CEO | PersonTitleTxt |
| Phone | 3016648612 | PhoneNum |
| Signature | 2021-03-19 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | ELIZABETH W HELLER | PreparerPersonNm |
| PTIN | P00397829 | PTIN |
| Phone | 2022932200 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2019 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ASHP FOUNDATION | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | STEVEN RUBLOFF | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4500 EAST-WEST HIGHWAY NO 900 | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $2,943,234 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.ASHPFOUNDATION.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1968 | FormationYr |
| Legal Domicile State | MD | LegalDomicileStateCd |
| Activity Or Mission | THE MISSION OF THE ASHP FOUNDATION IS TO SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE. | ActivityOrMissionDesc |
| Voting Members Governing Body | 12 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 9 | VotingMembersIndependentCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Total Volunteers | 125 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $1,768,602 | PYContributionsGrantsAmt |
| CY Contributions Grants | $928,082 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $512,137 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $1,118,585 | CYProgramServiceRevenueAmt |
| PY Investment Income | $483,729 | PYInvestmentIncomeAmt |
| CY Investment Income | $325,684 | CYInvestmentIncomeAmt |
| PY Other Revenue | $0 | PYOtherRevenueAmt |
| CY Other Revenue | $0 | CYOtherRevenueAmt |
| PY Total Revenue | $2,764,468 | PYTotalRevenueAmt |
| CY Total Revenue | $2,372,351 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $476,870 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $432,880 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $1,411,898 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $1,503,470 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $747,211 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $704,553 | PYOtherExpensesAmt |
| CY Other Expenses | $649,631 | CYOtherExpensesAmt |
| PY Total Expenses | $2,593,321 | PYTotalExpensesAmt |
| CY Total Expenses | $2,585,981 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $171,147 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$213,630 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $10,276,086 | TotalAssetsBOYAmt |
| Total Assets EOY | $9,865,167 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $854,211 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $864,752 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $9,421,875 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $9,000,415 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | OUR MISSION:SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE.OUR VISION:AS THE PHILANTHROPIC ARM OF ASHP, THE FOUNDATION SHARES ASHP'S VISION THAT MEDICATION USE WILL BE OPTIMAL, SAFE, AND EFFECTIVE FOR ALL PEOPLE ALL OF THE TIME. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $920,408 | ExpenseAmt |
| Grant | $194,985 | GrantAmt |
| Revenue | $610,795 | RevenueAmt |
| Desc | EXCELLENCE IN PHARMACY PRACTICE & LEADERSHIP DEVELOPMENT: RECOGNIZE AND PROMOTE EFFORTS THAT FOSTER EXCELLENCE AND GROWTH OF HEALTH-SYSTEM PHARMACYASHP STUDENT LEADERSHIP AWARD THIS PROGRAM, FUNDED THROUGH THE DAVID A. ZILZ FUND, IS ADMINISTERED BY THE ASHP PHARMACY STUDENT FORUM IN COLLABORATION WITH THE ASHP FOUNDATION. NINE STUDENTS WHO DEMONSTRATE HIGH ACADEMIC ACHIEVEMENT, EXCEPTIONAL INTEREST IN HEALTH-SYSTEM PHARMACY PRACTICE, AND OUTSTANDING LEADERSHIP SKILLS WERE RECOGNIZED. RECIPIENTS WERE: CLASS OF 2020 - LEAH SELZNICK, VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF PHARMACY, FALLS CHURCH, VA; JESSICA SHELLEY, OHIO NORTHERN UNIVERSITY RAABE COLLEGE OF PHARMACY, ADA, OHCLASS OF 2021 - UZO ABAJUE, TEXAS SOUTHERN UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCES, HOUSTON, TX; ALFRED AWUAH, UNIVERSITY OF GEORGIA COLLEGE OF PHARMACY, AUGUSTA, GA; AMY GUISINGER, UNIVERSITY OF NORTH CAROLINA ESHELMAN SCHOOL OF PHARMACY-CHAPEL HILL, CHAPEL HILL, NC; MORGAN JONES, UNIVERSITY OF CINCINNATI JAMES L.WINKLE COLLEGE OF PHARMACY, CINCINNATI, OH; AMEE JOSHI, THE OHIO STATE UNIVERSITY COLLEGE OF PHARMACY, COLUMBUS, OH; KAVEH OLOUMI, MIDWESTERN UNIVERSITY COLLEGE OF PHARMACY-GLENDALE, GLENDALE, AZCLASS OF 2021 - ATHENA TRIGLIA,OHIO NORTHERN UNIVERSITY RAABE COLLEGE OF PHARMACY, ADA, OHTHE AWARDEES RECEIVED A PLAQUE, A $2,000 AWARD AND AN ASHP DRUG INFORMATION LIBRARY. EACH AWARDEE SUBMITTED A PLAN TO RAISE STUDENT AWARENESS OF THE ASHP PRACTICE ADVANCEMENT INITIATIVE. AWARDEES WILL BE SURVEYED TO COLLECT INFORMATION ON IMPLEMENTATION AND OUTCOMES OF THEIR PLAN.PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAMTHE 2019 PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM WAS SUPPORTED AGAIN BY AMGEN, INC. THIS UNIQUE AWARD RECOGNIZES EXCELLENCE AND LEADERSHIP IN THE TRAINING AND MENTORING OF PHARMACY RESIDENTS. THE PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM RECOGNIZES A PRECEPTOR, NEW PRECEPTOR AND PROGRAM. THE OBJECTIVES OF THIS PROGRAM ARE TO: 1) RECOGNIZE THE ACHIEVEMENTS OF RESIDENCY PROGRAMS AND PHARMACISTS WHO HAVE DEMONSTRATED EXCELLENCE AND LEADERSHIP IN THE TRAINING OF PHARMACY RESIDENTS AND 2) WIDELY DISSEMINATE THE RESULTS OF THESE ACCOMPLISHMENTS TO FOSTER INNOVATIONS IN PHARMACY RESIDENT TRAINING. EACH AWARDEE WILL ALSO PRESENT AN EDUCATIONAL WEBINAR ON A RESIDENT PROFESSIONAL DEVELOPMENT TOPIC THAT CONTINUING EDUCATION CREDITS. THE WEBINARS ARE RECORDED AND MADE AVAILABLE FOR ON-DEMAND ACCESS. THE 2019 PROGRAM AND THE RECIPIENTS WERE:NEW PRECEPTOR: KATIE E. KORTE, PHARM.D., BCPS, BCCCP, TRUMAN MEDICAL CENTERS, KANSAS CITY, MOPRECEPTOR: JOEL C. MARRS, PHARM.D., BCPS, BCACP, BCCP, CLS, ASH-CHC, UNIVERSITY OF COLORADO SKAGGS SCHOOL OF PHARMACY, AURORA, COPROGRAM: UNIVERSITY OF COLORADO SKAGGS SCHOOL OF PHARMACY, PGY2, AMBULATORY CARE, AURORA, COLITERATURE AWARDS PROGRAMTHE ASHP FOUNDATION LITERATURE AWARDS PROGRAM RECOGNIZES IMPORTANT CONTRIBUTIONS TO THE BIOMEDICAL LITERATURE BY PHARMACISTS. THIS PROGRAM, ADMINISTERED BY THE ASHP FOUNDATION SINCE 1971, IS BASED ON THE CONCEPT THAT RECOGNITION THROUGH AWARDS STIMULATES RESEARCH AND INNOVATION AND FOSTERS IMPROVEMENT IN THE QUALITY OF THE EVIDENCE. AWARDEES ARE RECOGNIZED AT THE ASHP MIDYEAR CLINICAL MEETING DURING THE SPOTLIGHT ON SCIENCE PLENARY SESSION. THE 2019 RECIPIENTS WERE: SUSTAINED CONTRIBUTIONSVINCENT H. TAM, PHARM.D., FIDA, BCPS, UNIVERSITY OF HOUSTONPHARMACY PRACTICE RESEARCH "IMPACT OF A PHARMACIST-PHYSICIAN COLLABORATIVE CARE MODEL ON PATIENT OUTCOMES AND HEALTH SERVICES UTILIZATION"AM J HEALTH SYST PHARM. 2018 75GARY R. MATZKE, B.S.PHARM., PHARM.D., LETICIA R. MOCZYGEMBA, PHARM.D., KAREN J. WILLIAMS, PHARM.D., MICHAEL J. CZAR, B.S.PHARM., PH.D., WILLIAM T. LEE, B.S.PHARM., M.P.A.INNOVATION IN PHARMACY PRACTICE"IMPACT OF REQUIRING RE-AUTHORIZATION OF RESTRICTED ANTIBIOTICS ON DAY 3 OF THERAPY"J ANTIMICROB CHEMOTHER. 2018; 73:KHALID ELJAALY, SALWA ELARABI, SAMAH ALSHEHRI, AND DAVID E. NIX DRUG THERAPY RESEARCH "ASSOCIATION OF INHALED CORTICOSTEROIDS AND LONG-ACTING MUSCARINIC ANTAGONISTS WITH ASTHMA CONTROL IN PATIENTS WITH UNCONTROLLED, PERSISTENT ASTHMA A SYSTEMATIC REVIEW AND META-ANALYSIS"JAMA. 2018;319DIANA M. SOBIERAJ, PHARMD; WILLIAM L. BAKER, PHARMD; ELAINE NGUYEN, PHARMD, MPH; ERIN R. WEEDA, PHARMD; CRAIG I. COLEMAN, PHARMD; C. MICHAEL WHITE, PHARMD; STEPHEN C. LAZARUS, MD; KATHRYN V. BLAKE, PHARMD; JASON E. LANG, MD, MPH STUDENT RESEARCH AWARD"PHARMACOTHERAPY-INDUCED HEPATITIS B REACTIVATION AMONG PATIENTS WITH PRIOR FUNCTIONAL CURE: A SYSTEMATIC REVIEW"ANNALS OF PHARMACOTHERAPY. 2019; 53. 2018;7RHIANNON M. BATH, BRANDELYN E. DOERING, MICHAEL D. NAILOR, PHARMD,, KELLIE J. GOODLET, PHARMDEDUCATION PROGRAMSTRAINEESHIPSIN FY20, THE FOUNDATION ADMINISTERED ONE TRAINEESHIP. PAIN AND PALLIATIVE CARE TRAINEESHIP THE PAIN AND PALLIATIVE CARE TRAINEESHIP INCLUDED ACCESS TO THE ASHP PAIN MANAGEMENT CERTIFICATE AND LIVE CASE-BASED WEBINARS, AN EXPERIENTIAL TRAINING COMPONENT, AND A POST-TRAINEESHIP PROJECT COMPONENT, WHICH WAS SUPPORTED THROUGH PARTICIPANT TUITION. IN FY20, 6 PHARMACISTS WERE ACCEPTED INTO THE TRAINEESHIP. DUE TO COVID19 RESTRICTIONS AND CONCERNS, THE DISTANCE EDUCATION WAS POSTPONED AND WILL BE SCHEDULED IN FY21. OTHER EDUCATIONAL PROGRAMSJOSEPH A. ODDIS COLLOQUIUMTHE COLLOQUIUM WAS ESTABLISHED TO PAY TRIBUTE TO ONE OF PHARMACY'S MOST DISTINGUISHED LEADERS AND ASSIST HEALTH-SYSTEM PHARMACISTS IN CONFRONTING ETHICAL CHALLENGES IN PHARMACY PRACTICE AND PATIENT CARE. THE 2019 COLLOQUIUM WAS OFFERED AS A LIVE EDUCATIONAL ACTIVITY PLANNED FOR THE 2019 ASHP SUMMER MEETINGS. PHARMACY RESIDENCY EXPANSION GRANTIN FY20, THE ASHP FOUNDATION, SUPPORTED BY EDUCATIONAL DONATIONS FROM ABBVIE AND MERCK, AWARDED $125,000 DOLLARS IN GRANTS TO PGY-1 AND PGY-2 PHARMACY RESIDENCY PROGRAMS TO INCREASE THE NUMBER OF AVAILABLE TRAINING POSITIONS. THERE WERE 5 GRANTS AWARDED. RECIPIENTS WERE: PARKVIEW HEALTH, BAPTIST HEALTH FLOYD, UNIVERSITY OF ILLINOIS AT CHICAGO COLLEGE OF PHARMACY AT ROCKFORD, GEISINGER MEDICAL CENTER, AND UNIVERSITY OF MARYLAND MEDICAL CENTER PHARMACY STUDENT CLINICAL SKILLS COMPETITIONMARY CASH AND SARA SCOTT, UNIVERSITY OF NORTH CAROLINA ESHELMAN SCHOOL OF PHARMACY COMPETED AGAINST OTHER TEAMS AT THE 2019 ASHP NATIONAL CLINICAL SKILLS COMPETITIONSM, HELD IN DECEMBER 2019, DURING THE ASHP MIDYEAR CLINICAL MEETING IN LAS VEGAS, NV. THE FOUNDATION HAS SPONSORED THE PHARMACY STUDENT CLINICAL SKILLS COMPETITION (CSC) AT THE ASHP MIDYEAR CLINICAL MEETING 14 YEARS. TEAMS WHO WON PRELIMINARY COMPETITIONS AT THEIR LOCAL PHARMACY SCHOOL PARTICIPATED IN THE COMPETITION. DURING THE CSC, STUDENTS DEMONSTRATE THEIR SKILLS BY ASSESSING PATIENT INFORMATION AND CURRENT THERAPY, IDENTIFYING AND PRIORITIZING DRUG THERAPY PROBLEMS, IDENTIFYING TREATMENT GOALS, AND RECOMMENDING A PHARMACIST CARE PLAN. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $666,743 | ExpenseAmt |
| Grant | $237,895 | GrantAmt |
| Desc | INNOVATIVE RESEARCH: SUPPORT HEALTH SERVICES RESEARCH THAT FOSTER INNOVATION IN PHARMACY PRACTICE, WHICH PROMOTES THE OPTIMAL, SAFE AND EFFECTIVE USE OF MEDICATION.AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION (AFPE) PRE-DOCTORAL FELLOWSHIP THE ASHP FOUNDATION PROVIDED ANNUAL FUNDING OF $7,500 FOR THE AFPE PRE-DOCTORAL FELLOWSHIP PROGRAM. PHARMACY RESIDENT PRACTICE-BASED RESEARCH GRANT PROGRAM THIS GRANT PROGRAM IS FUNDED THROUGH THE ASHP MEMBER DUES CONTRIBUTION TO THE FOUNDATION. A SIX-MEMBER EXTERNAL PEER REVIEW PANEL RECOMMENDED AWARDING 8 GRANTS UP TO $5,000 EACH FOR:"CLINICAL AND ECONOMIC IMPACT OF INCORPORATING A PHARMACY TECHNICIAN INTO A MEDICATION MONITORING PROGRAM"HLEE LOR, PHARM.D KAISER PERMANENTE COLORADO, DENVER, CO "EVALUATION OF A PHARMACIST-LED OUTPATIENT ANTIBIOTIC STEWARDSHIP PROGRAM AND IMPLEMENTATION OF PRESCRIBING ORDER SETS" CURTIS BLOW, PHARM.D SUNY UPSTATE MEDICAL UNIVERSITY - UPSTATE HEALTH CARE CENTER, SYRACUSE, NY"ASSESSING THE IMPACT OF RURALBASED AMBULATORY PHARMACIST ON DIABETES CARE THROUGH PERCEPTIONS OF ADVANCED MONITORING TECHNOLOGIES" JEREMY SPARKS, PHARM.DUNIVERSITY OF FLORIDA, GAINESVILLE, FL"DEVELOPMENT AND VALIDATION OF A PHARMACIST TRANSITIONS OF CARE TOOL USING MACHINE LEARNING ALGORITHMS TO PREDICT REHOSPITALIZATION IN CHRONIC HEART FAILURE" MELISSA RIESTER, PHARM.D RHODE ISLAND HOSPITAL, PROVIDENCE, RI"DEVELOPMENT OF A NOVEL PHARMACIST-LED OPIOID DEPRESCRIBING PROTOCOL FOR OLDER ADULTS"ALISSA MARGRAF, PHARM.DRHODE ISLAND HOSPITAL/LIFESPAN PHARMACY, PROVIDENCE, RI"PHARMACIST-DRIVEN FLUID STEWARDSHIP IN THE NEUROINTENSIVE CARE"BROOKE BARLOW, PHARM.DUNIVERSITY OF KENTUCKY HEALTHCARE, LEXINGTON KY"EXPANDING SERVICES OF A PHARMACIST-LED RURAL MOBILE HEALTH CLINIC TO SCHOOL-AGED CHILDREN AND WORKING CLASS PARENTS" MEGAN STEPHAN, PHARM.DOHIO NORTHERN UNIVERSITY, ADA, OH"IMPLEMENTATION AND EVALUATION OF AN ABC INVENTORY MODEL IN A CANCER CENTER PHARMACY AT A LARGE ACADEMIC MEDICAL CENTER"ROBERT ROSE UNIVERSITY OF NORTH CAROLINA MEDICAL CENTER, CHAPEL HILL, NCPHARMACY PRACTICE ADVANCEMENT DEMONSTRATION GRANTTWELVE LETTER OF INTENT AND FULL APPLICATIONS WERE REVIEWED BY EXTERNAL REVIEW PANEL IN ORDER TO AWARD THE FY20 GRANTEES. THIS RESEARCH GRANT PROGRAM SUPPORTS DEMONSTRATION PROJECTS RELATED TO PRACTICE ADVANCEMENT, CONSISTENT WITH THE ASHP/ASHP FOUNDATION PRACTICE ADVANCEMENT INITIATIVE. GRANT FUNDS WERE PROVIDED BY THE BAXTER ENDOWMENT AND EACH GRANTEE WAS AWARDED UP TO $75,000. "IMPACT OF AN INTEGRATED PHARMACIST AND PRIMARY CARE COLLABORATIVE TRANSITIONS OF CARE PROGRAM ON CLINICAL AND ECONOMIC OUTCOMES AMONG HIGH RISK PATIENTS" INVESTIGATOR DAVID JACOBS, PHARM.D., PH.D.UNIVERSITY AT BUFFALO SCHOOL OF PHARMACY AND PHARMACEUTICAL SCIENCES, BUFFALO, NY"AN EVALUATION OF THE CLINICAL IMPACT OF PHARMACIST IMPLEMENTATION OF ANTIMICROBIAL STEWARDSHIP PROGRAM IN A PRIMARY CARE SETTING: A PILOT STUDY"INVESTIGATOR: ARINZE NKEMDIRIM OKERE, PHARM.D.FLORIDA A&M UNIVERSITY, TALLAHASSEE, FLNEW PRACTITIONER PHARMACIST LEADERSHIP DEVELOPMENT RESEARCH GRANT PROGRAM THIS NEW GRANT PROGRAM, FUNDED THROUGH THE MARIANNE F. IVEY LEADERSHIP DEVELOPMENT FUND, AWARDS NEW PRACTITIONER PHARMACISTS TO SUPPORT DIVERSE PROJECTS RELATED TO LEADERSHIP DEVELOP RESEARCH. AREAS OF FOCUS INCLUDE, MODEL DEMONSTRATION PROJECTS, SYSTEMS CHANGE PROJECTS, SPECIAL STUDIES AND EVALUATIONS THAT ARE FOCUSED ON DEVELOPING LEADERSHIP COMPETENCIES. A SIX-MEMBER EXTERNAL PEER REVIEW PANEL RECOMMENDED AWARDING 4 GRANTS UP TO $5,000 EACH FOR:"EVALUATING THE EFFECTS OF A MINDFULNESS MOBILE APPLICATION ON STUDENT PHARMACISTS' STRESS, MINDFULNESS AND BURNOUT."ANGELA CHU, PHARM.D, BCPS ROSEMAN UNIVERSITY OF HEALTH SCIENCES, HENDERSON, NV"EVALUATION OF BURNOUT AMONG PHARMACY RESIDENTS IN THE UNITED STATES."DEREK GYORI, PHARM. D., BCOP UNIVERSITY OF TOLEDO COLLEGE OF PHARMACY AND PHARMACEUTICAL SCIENCES,TOLEDO, OH"THE EFFECT OF SELF-LEADERSHIP ON BURNOUT AMONG PGY-1 PHARMACY PRACTICE RESIDENTS"CHIEMENA OHANELE, PHARM.D, RPH HOWARD UNIVERSITY COLLEGE OF PHARMACY, WASHINGTON, DC"THE EFFECT OF SELF-LEADERSHIP ON BURNOUT AMONG PGY-1 PHARMACY PRACTICE RESIDENTS"STACY PASCIOLLA, PHARM.D UNIVERSITY OF THE SCIENCES, PHILADELPHIA, PARESEARCH ADVISORY COUNCIL IN FY20, THE ASHP FOUNDATION ESTABLISHED A RESEARCH ADVISORY COUNCIL TO GUIDE THE FOCUS AND EXPANSION OF OUR RESEARCH PROGRAM. THE COUNCIL MET AT ASHP HEADQUARTERS IN JANUARY 2020 AND DEVELOPED A RESEARCH AGENDA FRAMEWORK OF CORE PRINCIPLES AND PRIORITY RESEARCH AREAS THAT ALIGN WITH THE FOUNDATION'S MISSION AND ASHP'S MAJOR PRIORITIES AND ARE AT THE FOREFRONT OF THE NATIONAL HEALTHCARE AGENDA. TOOLS AND RESOURCESHARVEY A. K. WHITNEY AWARD LECTURES ONLINE COLLECTION PROGRAMTHE HARVEY A.K. WHITNEY AWARD IS THE MOST PRESTIGIOUS AWARD IN HEALTH-SYSTEM PHARMACY. THE WHITNEY AWARD LECTURES ONLINE COLLECTION PROGRAM INCLUDES A WEBSITE FOR DISSEMINATION OF WHITNEY LECTURES. THE WEBSITE PROVIDES ACCESS TO MORE THAN 60 LECTURES THAT CAN BE BROWSED BY TITLE, AUTHOR, PUBLICATION DATE OR KEYWORD. THESE LECTURES REPRESENT MORE THAN 50 YEARS OF EXCELLENCE IN PHARMACY PRACTICE, PROVIDING A UNIQUE GLIMPSE INTO OUR COLLECTIVE PAST, A COMMENTARY ON THE PRESENT, AND AN OUTLINE OF THE CHALLENGES AND OPPORTUNITIES THAT LIE AHEAD. LEADERSHIP PROGRAMSPHARMACY FORECAST REPORT 2020THE 2020 PHARMACY FORECAST REPORT WAS SUPPORTED BY A GRANT FROM OMNICELL, INC., TO THE ASHP FOUNDATION'S DAVID A. ZILZ LEADERS FOR THE FUTURE FUND AND WAS PUBLISHED IN AJHP IN THE JANUARY 15, 2020 ISSUE. THE DISTRIBUTION OF THE FORECAST REPORT IN AJHP ENSURED THAT IT WAS MADE AVAILABLE TO ALL 55,000 ASHP MEMBERS. IT WAS PUBLISHED ELECTRONICALLY IN DECEMBER 2019 AND PRESENTED AT AN EDUCATIONAL SESSION DURING THE 2019 ASHP MIDYEAR CLINICAL MEETING. THE REPORT GENERATED AUTHORITATIVE, ACTIONABLE STRATEGIC RECOMMENDATIONS TO ENHANCE THE EFFECTIVENESS OF LEADERS IN HOSPITAL AND HEALTH-SYSTEM PHARMACY. IT ALSO INCLUDED A CHAPTER ON "BLACK SWAN" EVENTS AND ITS IMPACT ON PHARMACY. VISITING LEADERS PROGRAM (VLP)THE VISITING LEADERS PROGRAM, WITH SUPPORT FROM THE DAVID A. ZILZ LEADERS FOR THE FUTURE FUND, HAD ANOTHER SUCCESSFUL YEAR. ELEVEN LEADERS WERE INVOLVED IN 14 RESIDENCY VISITS, REACHING MORE HUNDREDS OF RESIDENTS IN 14 STATES IN FY20. THE PROGRAM OFFERS AN HONORARIUM AND TRAVEL EXPENSE REIMBURSEMENT TO THE PHARMACIST LEADERS TO CONDUCT THE 2-DAY VISIT TO SELECTED RESIDENCY PROGRAMS. AN ADDITIONAL 7 VISITS WERE POSTPONED BECAUSE OF COVID19 AND WILL BE RESCHEDULED IN FY21.PHARMACY LEADERSHIP ACADEMY (PLA) THE PLA, SUPPORTED IN PART BY AN EDUCATIONAL GRANT FROM AMGEN, INC. AND APEXIS, IS AN ONLINE EDUCATION PROGRAM DESIGNED TO PROVIDE COMPREHENSIVE LEADERSHIP EDUCATION TO PHARMACISTS. THE PLA CLASS IN FY20 CONSISTED OF 100 PARTICIPANTS, WHO ALSO REMITTED TUITION AND WERE ENROLLED IN THE PROGRAM FROM JULY 2019 JUNE 2020. THE NUMBER OF GRADUATES IN BRINGS THE TOTAL NUMBER OF PLA GRADUATES TO 866 PHARMACISTS.STUDENT LEADERSHIP DEVELOPMENT WORKSHOP THE 3-HOUR LEADERSHIP DEVELOPMENT WORKSHOP FOR PHARMACY STUDENTS IS CONDUCTED ANNUALLY AT THE ASHP SUMMER MEETINGS. STATE AFFILIATES HAVE TAKEN ADVANTAGE OF THE PROGRAM TO ENGAGE STUDENTS AT THEIR ANNUAL MEETINGS. NO WORKSHOPS WERE SCHEDULED IN FY20 BECAUSE OF COVID19. LEADERSHIP SPEAKERS BUREAUA PROGRAM DESIGNED TO HAVE PHARMACY LEADERS SPEND ONE DAY WITH STUDENTS IN A LOCAL SCHOOL OF PHARMACY'S STUDENT SOCIETY OF HEALTH-SYSTEM PHARMACISTS (SSHP) TO DISCUSS EMERGING LEADERSHIP TOPICS. THE SSHP'S HAVE THE OPPORTUNITY TO SUBMIT RECEIPTS FOR REIMBURSEMENT OF UP TO $200 TO HELP COVER EXPENSES DURING THE VISIT. NO SSHP SUBMITTED EXPENSES FOR REIMBURSEMENT IN FY20. THE WILLIAM A. ZELLMER LECTURE A DISTINGUISHED SPEAKER IS INVITED TO ADDRESS THE PRACTICE LEADERS OF ASHP DURING ASHP POLICY WEEK ON AN ANNUAL BASIS. THROUGH THE LECTURE FUND, HEALTH-SYSTEM PHARMACY LEADERS FROM AROUND THE COUNTRY WILL CONTINUE TO BE INSPIRED AND CONFRONTED BY LEADING THINKERS REGARDING CONCERNS FACING PHARMACY AND HEALTHCARE. ERIN R. FOX, SENIOR DIRECTOR OF DRUG INFORMATION AND SUPPORT SERVICES AT UNIVERSITY OF UTAH HEALTH, HAS ADVICE FOR PHARMACY COLLEAGUES ABOUT HOW TO SHAPE POLICY AND DRIVE NATIONAL CONVERSATIONS ON ISSUES THAT ARE IMPORTANT TO THE PROFESSION. "THINK BIG. YOU CAN MAKE A DIFFERENCE," SHE SAID SEPT. 10 WHILE PRESENTING THE 2019 WILLIAM A. ZELLMER LECTURE IN BETHESDA, MARYLAND. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Revenue | $476,790 | RevenueAmt |
| Desc | THE ASHP FOUNDATION CORPORATE PARTNERS PROGRAM IS A STRATEGIC PARTNERSHIP BETWEEN THE ASHP FOUNDATION, ASHP, AND CORPORATIONS WHICH PROMOTES MEDICATION SAFETY AND IMPROVEMENTS IN PATIENT CARE. THE PROGRAM OFFERS A ROBUST MENU OF SPONSORSHIP LEVELS AND BENEFITS FOR COMPANIES, FOCUSED ON COLLABORATION, RECOGNITION, AND INFORMATIONAL OPPORTUNITIES. THERE ARE FOUR SPONSORSHIP LEVELS AND A-LA-CARTE OPPORTUNITIES TO BETTER MEET BUSINESS OBJECTIVES. CORPORATE PARTNERS PROGRAM SPONSORSHIP IS ON AN ANNUAL BASIS. WITH THE GENEROUS SUPPORT OF CORPORATE PARTNERS, THE ASHP FOUNDATION INVESTS IN RESEARCH, AWARDS, EDUCATION, AND LEADERSHIP DEVELOPMENT THAT ADVANCES THE PHARMACY PROFESSION AND ENSURES THE SAFE, EFFECTIVE, AND OPTIMAL USE OF MEDICATIONS. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $1,587,151 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (1) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | 0 | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | 0 | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | 0 | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (1) | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | Yes (1) | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 61 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 0 | EmployeeCnt |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 12 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 9 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | 0 | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | 0 | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | TRACY YAKLYVICH | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 3016648696 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4500 EAST-WEST HIGHWAY SUITE 900 | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (16 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| JOHN T TIGHE III | ||||||||
| CHAIR | 1.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| R EDWARD HOWELL | ||||||||
| VICE CHAIR | 1.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| PAUL W ABRAMOWITZ | ||||||||
| PRESIDENT/ASHP CEO | 3.00 | 37.50 | Yes (X) | Yes (X) | $0 | $917,893 | $54,033 | |
| CHRISTENE JOLOWSKY | ||||||||
| TREASURER | 1.00 | 4.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| THOMAS J JOHNSON | ||||||||
| TREASURER (THRU 8/19); ASHP PRESIDENT-ELECT | 1.00 | 5.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| STEVEN A RUBLOFF | ||||||||
| SECY/ASHP REF CEO | 40.00 | 0.00 | Yes (X) | Yes (X) | $337,637 | $0 | $45,552 | |
| ROGER W ANDERSON | ||||||||
| DIRECTOR AT LARGE | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| MINNIE BAYLOR-HENRY | ||||||||
| DIRECTOR AT LARGE | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| JANET L MIGHTY | ||||||||
| DIRECTOR AT LARGE | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| KEN PEREZ | ||||||||
| DIRECTOR AT LARGE | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| THOMAS J RICE | ||||||||
| DIRECTOR AT LARGE | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| SCOTT M SAMSON | ||||||||
| DIRECTOR AT LARGE | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||
| KELLY M SMITH | ||||||||
| DIRECTOR AT LARGE | 1.00 | 5.00 | Yes (X) | $0 | $10,150 | $0 | ||
| KATHLEEN S PAWLICKI | ||||||||
| ASHP PRESIDENT | 1.00 | 5.00 | Yes (X) | $0 | $10,150 | $0 | ||
| BARBARA NUSSBAUM | ||||||||
| VP FOR RESEARCH AND EDUCATION | 40.00 | 0.00 | $180,091 | $0 | $52,876 | Yes (X) | ||
| STEPHANIE BROWN | ||||||||
| DIRECTOR, FOUNDATION OPERATIONS | 40.00 | 0.00 | $117,258 | $0 | $22,610 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $634,986 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $938,193 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $175,071 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 0 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
| Cntrct Rcvd Greater Than100 K | 0 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $357,100 | RelatedOrganizationsAmt |
| All Other Contributions | $570,982 | AllOtherContributionsAmt |
| Total Contributions | $928,082 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (4 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | ExclusionExclusionAmt |
|---|---|---|---|---|
| PHARMACY LEADERSHIP AC | 611430 | $605,295 | $605,295 | |
| CORPORATE PARTNER PROG | 611430 | $476,790 | $476,790 | |
| SPONSORSHIPS | 900099 | $31,000 | $31,000 | |
| PAIN & PALLIATIVE TRAI | 611430 | $5,500 | $5,500 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $1,118,585 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $303,024 | TotalRevenueColumnAmt |
| Exclusion | $303,024 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $593,543 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $570,883 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $22,660 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $22,660 | TotalRevenueColumnAmt |
| Exclusion | $22,660 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,372,351 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $1,087,585 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $356,684 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $397,535 | TotalAmt |
| Program Services | $397,535 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $35,345 | TotalAmt |
| Program Services | $35,345 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $388,499 | TotalAmt |
| Program Services | $187,039 | ProgramServicesAmt |
| Management And General | $28,901 | ManagementAndGeneralAmt |
| Fundraising | $172,559 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $850,258 | TotalAmt |
| Program Services | $409,803 | ProgramServicesAmt |
| Management And General | $61,581 | ManagementAndGeneralAmt |
| Fundraising | $378,874 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $105,393 | TotalAmt |
| Program Services | $56,955 | ProgramServicesAmt |
| Management And General | $9,166 | ManagementAndGeneralAmt |
| Fundraising | $39,272 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $86,780 | TotalAmt |
| Program Services | $39,939 | ProgramServicesAmt |
| Management And General | $7,600 | ManagementAndGeneralAmt |
| Fundraising | $39,241 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $72,540 | TotalAmt |
| Program Services | $36,524 | ProgramServicesAmt |
| Management And General | $4,456 | ManagementAndGeneralAmt |
| Fundraising | $31,560 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $12,500 | TotalAmt |
| Management And General | $12,500 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $420,434 | TotalAmt |
| Program Services | $314,350 | ProgramServicesAmt |
| Management And General | $75,953 | ManagementAndGeneralAmt |
| Fundraising | $30,131 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $52,764 | TotalAmt |
| Program Services | $45,299 | ProgramServicesAmt |
| Management And General | $6,859 | ManagementAndGeneralAmt |
| Fundraising | $606 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,100 | TotalAmt |
| Management And General | $1,100 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $126,878 | TotalAmt |
| Program Services | $58,202 | ProgramServicesAmt |
| Management And General | $17,113 | ManagementAndGeneralAmt |
| Fundraising | $51,563 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $24,496 | TotalAmt |
| Management And General | $24,496 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | GENERAL EXPENSES | Desc |
| Total | $11,459 | TotalAmt |
| Program Services | $6,160 | ProgramServicesAmt |
| Management And General | $1,894 | ManagementAndGeneralAmt |
| Fundraising | $3,405 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,585,981 | TotalAmt |
| Program Services | $1,587,151 | ProgramServicesAmt |
| Management And General | $251,619 | ManagementAndGeneralAmt |
| Fundraising | $747,211 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $81,749 | BOYAmt |
| EOY | $160,544 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $189,363 | BOYAmt |
| EOY | $21,418 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $602,196 | BOYAmt |
| EOY | $401,165 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $242,712 | BOYAmt |
| EOY | $40,644 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $283,347 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $97,081 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,398 | BOYAmt |
| EOY | $186,266 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,971,882 | BOYAmt |
| EOY | $8,914,470 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $161,768 | BOYAmt |
| EOY | $125,642 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $15,018 | BOYAmt |
| EOY | $15,018 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,276,086 | BOYAmt |
| EOY | $9,865,167 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $277,949 | BOYAmt |
| EOY | $307,673 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $576,262 | BOYAmt |
| EOY | $557,079 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $854,211 | BOYAmt |
| EOY | $864,752 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,471,468 | BOYAmt |
| EOY | $1,506,384 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,950,407 | BOYAmt |
| EOY | $7,494,031 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,421,875 | BOYAmt |
| EOY | $9,000,415 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,276,086 | BOYAmt |
| EOY | $9,865,167 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | -$213,630 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$207,830 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consol And Sep Basis Fincl Stmt | Yes (X) | ConsolAndSepBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $2,055,036 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,799,986 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $2,088,349 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,768,602 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $928,082 | CurrentTaxYearAmt |
| Total | $8,640,055 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $2,055,036 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,799,986 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $2,088,349 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,768,602 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $928,082 | CurrentTaxYearAmt |
| Total | $8,640,055 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $3,945,100 | SubstantialContributorsTotAmt |
| Public Support Total170 | $4,694,955 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $294,198 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $270,016 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $315,175 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $406,338 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $303,024 | CurrentTaxYearAmt |
| Total | $1,588,751 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $10,228,806 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $3,442,131 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.45900 | PublicSupportCY170Pct |
| Public Support PY170 | 0.47510 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,808,429 | BeginningYearBalanceAmt |
| Contributions | $1,300 | ContributionsAmt |
| Investment Earnings Or Losses | $106,680 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $185,232 | OtherExpendituresAmt |
| End Year Balance | $6,731,177 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,838,821 | BeginningYearBalanceAmt |
| Contributions | $1,480 | ContributionsAmt |
| Investment Earnings Or Losses | $93,478 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $125,350 | OtherExpendituresAmt |
| End Year Balance | $6,808,429 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,732,965 | BeginningYearBalanceAmt |
| Contributions | $6,019 | ContributionsAmt |
| Investment Earnings Or Losses | $423,554 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $323,717 | OtherExpendituresAmt |
| End Year Balance | $6,838,821 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,264,149 | BeginningYearBalanceAmt |
| Contributions | $291,302 | ContributionsAmt |
| Investment Earnings Or Losses | $654,392 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $476,878 | OtherExpendituresAmt |
| End Year Balance | $6,732,965 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,403,208 | BeginningYearBalanceAmt |
| Contributions | $1,700 | ContributionsAmt |
| Investment Earnings Or Losses | -$65,917 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $74,842 | OtherExpendituresAmt |
| End Year Balance | $6,264,149 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.07430 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.75660 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.16910 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | 0 | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | 0 | EndowmentsHeldRelatedOrgInd |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $83,984 | OtherCostOrOtherBasisAmt |
| Depreciation | $77,145 | DepreciationAmt |
| Book Value | $6,839 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $199,363 | OtherCostOrOtherBasisAmt |
| Depreciation | $19,936 | DepreciationAmt |
| Book Value | $179,427 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $186,266 | TotalBookValueLandBuildingsAmt |
| Total Rev Etc Audited Fincl Stmt | $2,411,124 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$207,830 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $246,603 | DonatedServicesAndUseFcltsAmt |
| Revenue Not Reported | $38,773 | RevenueNotReportedAmt |
| Revenue Subtotal | $2,372,351 | RevenueSubtotalAmt |
| Revenue Not Reported Fincl Stmt | $0 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $2,372,351 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $2,832,584 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $246,603 | DonatedServicesUseFcltsAmt |
| Expenses Not Reported | $246,603 | ExpensesNotReportedAmt |
| Expenses Subtotal | $2,585,981 | ExpensesSubtotalAmt |
| Expenses Not Rpt Fincl Stmt | $0 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $2,585,981 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART V, LINE 4: | FormAndLineReferenceDesc |
| Explanation | THE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH IS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (14 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION | |||||||
| ONE CHURCH STREET | ROCKVILLE | MD | 20850 | 530214882 | 501(C)3 | $7,500 | 2019 SPONSORSHIP |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISITS | |||||||
| 4500 EAST-WEST HIGHWAY | BETHESDA | MD | 20814 | 520807628 | 501(C)6 | $34,640 | CLINICAL SKILLS COMPETITION |
| EDWARD VIA VIRGINIA COLLEGE OF OSTEOPATHIC MEDICINE | |||||||
| 2265 KRAFT DRIVE | BLACKSBURG | VA | 24060 | 542052107 | 501(C)3 | $6,800 | NEW INVESTIGATOR RESEARCH GRANT |
| UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | |||||||
| 109 KINKEAD HALL | LEXINGTON | KY | 40506 | 616033693 | 501(C)3 | $6,611 | NEW INVESTIGATOR RESEARCH GRANT |
| PURDUE UNIVERSITY | |||||||
| 1281 WIN HENTSCHEL BLVD | WEST LAFAYETTE | IN | 47906 | 356002041 | 501(C)3 | $25,388 | 2016 PHARMACY PRACTICE MODEL GRANT |
| DENT NEUROSCIENCES RESEARCH CENTER INC | |||||||
| 3980 SHERIDAN DRIVE SUITE 500 | AMHERST | NY | 14226 | 161583617 | 501(C)3 | $23,382 | 2019 PRACTICE ADVANCEMENT DEMO GRANT |
| UNIVERSITY OF TENNESSEE | |||||||
| 201 ANDY HOLT TOWER | KNOXVILLE | TN | 37996 | 626001636 | 501(C)3 | $24,750 | 2019 PRACTICE ADVANCEMENT DEMO GRANT |
| RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | |||||||
| PO BOX 9 | ALBANY | NY | 12201 | 141368361 | 501(C)3 | $24,750 | 2019 PRACTICE ADVANCEMENT DEMO GRANT |
| FLORIDA A&M UNIVERSITY | |||||||
| 1700 LEE HALL DRIVE | TALLAHASSEE | FL | 32307 | 590977035 | STATE AGENCY | $24,750 | 2019 PRACTICE ADVANCEMENT DEMO GRANT |
| GEISINGER MEDICAL CENTER | |||||||
| 100 NORTH ACADEMY AVENUE | DANVILLE | PA | 17822 | 240795959 | 501(C)3 | $25,000 | RESIDENCY EXPANSION GRANT |
| BOARD OF TRUSTEES OF THE UNIV OF ILLINOIS | |||||||
| 506 S WRIGHT STREET | URBANA | IL | 61801 | 376000511 | STATE AGENCY | $25,000 | RESIDENCY EXPANSION GRANT |
| PARKVIEW HOSPITAL INC | |||||||
| 11109 PARKVIEW PLAZA DRIVE | FORT WAYNE | IN | 46845 | 350868085 | 501(C)3 | $25,000 | RESIDENCY EXPANSION GRANT |
| UNIVERSITY OF MARYLAND MEDICAL SYSTEM CORPORATION | |||||||
| 22 SOUTH GREENE STREET | BALTIMORE | MD | 21201 | 521362793 | 501(C)3 | $25,000 | RESIDENCY EXPANSION GRANT |
| BAPTIST HEALTHCARE SYSTEM INC | |||||||
| 2701 EASTPOINT PARKWAY | LOUISVILLE | KY | 40223 | 610444707 | 501(C)3 | $25,000 | RESIDENCY EXPANSION GRANT |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 13 | Total501c3OrgCnt |
| Total Other Org | 1 | TotalOtherOrgCnt |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)
| Grant TypeGrantTypeTxt | RecipientRecipientCnt | Cash GrantCashGrantAmt |
|---|---|---|
| LITERATURE AWARD | 8 | $17,345 |
| STUDENT LEADERSHIP AWARDS | 9 | $18,000 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. ANY UNUSED GRANT FUNDS MUST BE RETURNED. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | Yes (1) | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | Yes (1) | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (1) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (3 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PAUL W ABRAMOWITZ | ||||||||||||||
| PRESIDENT/ASHP CEO | $0 | $771,153 | $0 | $115,500 | $0 | $31,240 | $0 | $27,700 | $0 | $31,162 | $0 | $976,755 | $0 | $0 |
| STEVEN A RUBLOFF | ||||||||||||||
| SECY/ASHP REF CEO | $311,395 | $0 | $25,000 | $0 | $1,242 | $0 | $11,200 | $0 | $39,662 | $0 | $388,499 | $0 | $0 | $0 |
| BARBARA NUSSBAUM | ||||||||||||||
| VP FOR RESEARCH AND EDUCATION | $171,234 | $0 | $7,875 | $0 | $982 | $0 | $18,524 | $0 | $40,181 | $0 | $238,796 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 3 | THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED ORGANIZATION, USES THE FOLLOWING TO ESTABLISH COMPENSATION OF ITS CEO: COMPENSATION COMMITTEE, WRITTEN EMPLOYMENT CONTRACT, COMPENSATION SURVEY OR STUDY, FORM 990 OF OTHER ORGANIZATIONS, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE. |
| PART I, LINE 6 | PAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF SECRETARY/ASHP REF CEO, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL AND NON-FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS. |
| PART I, LINE 7 | ALL ASHP-REF EMPLOYEES ARE ELIGIBLE FOR AN ANNUAL PERFORMANCE INCENTIVE PROGRAM IN ACCORDANCE WITH POLICY, AT THE DISCRETION OF THE BOARD OF DIRECTORS, BASED ON MUTUALLY AGREED UPON PREDETERMINED OBJECTIVES. |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (7 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 7A | THREE MANDATORY MEMBERS OF THE FOUNDATION'S BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, CEO, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND CEO SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD. |
| FORM 990, PART VI, SECTION A, LINE 8B | THERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS REVIEWED BY THE CHIEF OPERATIONS AND FINANCIAL OFFICERS AND BY THE BOARD BEFORE IT IS FILED. EACH MEMBER HAS THE OPPORTUNITY TO REVIEW THE FORM 990. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE CONFLICT OF INTEREST POLICY WILL BE REVIEWED ANNUALLY AT THE SPRING OR FALL MEETING |
| FORM 990, PART VI, SECTION B, LINE 15A | CEO, EXECUTIVE DIRECTOR OR TOP MANAGEMENT: A "CEO EVALUATION SUBCOMMITTEE" IS APPOINTED BY THE BOARD AND MEETS SEVERAL TIMES ON AN ANNUAL BASIS. THIS SUBCOMMITTEE IS RESPONSIBLE FOR EVALUATING CEO PERFORMANCE ANNUALLY AND NEGOTIATING A CONTRACT THAT CUSTOMARILY SPANS A 3-YEAR PERIOD. THE TREASURER CHAIRS THE SUBCOMMITTEE DURING THE CONTRACT RENEGOTIATION YEAR AND THE BOARD CHAIR LEADS THE SUBCOMMITTEE DURING NON-CONTRACT YEAR ANNUAL REVIEWS. ALL SUBCOMMITTEE ACTIONS ARE REVIEWED BY THE FULL BOARD PRIOR TO TAKING ANY ACTIONS. ONE FULL YEAR PRIOR TO THE COMPLETION OF A CONTRACT CYCLE, THE SUBCOMMITTEE MAKES A REFLECTIVE REVIEW OF PERFORMANCE DURING THE CONTRACT PERIOD. ADDITIONALLY, A CEO SELF-ASSESSMENT IS COMPLETED AND REVIEWED BY THE SUBCOMMITTEE. THE REFLECTIVE PERFORMANCE REVIEW AND SELF-ASSESSMENT IS CONSIDERED BY THE BOARD AND A DECISION IS MADE AS TO WHETHER THE BOARD DESIRES TO RENEGOTIATE A NEW CONTRACT WITH THE EXISTING CEO OR SEEK A REPLACEMENT. IF A REPLACEMENT IS DESIRED, THEN A SEARCH COMMITTEE IS APPOINTED. IF CONTRACT RENEGOTIATION WITH THE CURRENT CEO IS DESIRED, THE CEO EVALUATION COMMITTEE LEADS CONTRACT RENEGOTIATIONS UNDER THE LEADERSHIP OF THE TREASURER. A CONTRACT FOR THE BOARD'S CONSIDERATION IS ESTABLISHED IN WRITING WITH ALL PROVISIONS OUTLINED, INCLUDING COMPENSATION AND BENEFITS. TO DETERMINE PROPOSED COMPENSATION THE SUBCOMMITTEE REVIEWS 1) NATIONAL SURVEY DATA FOR THE CEO POSITION; 2) THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVE (ASAE) COMPENSATION DATA FOR EXECUTIVES IS REVIEWED FOCUSING ON SIMILAR/COMPETITIVE HEALTHCARE ORGANIZATIONS IN THE MID-ATLANTIC REGION; AND 3) GUIDESTAR'S DATABASE IS REFERENCED TO IDENTIFY CEO COMPENSATION IN COMPETITIVE ORGANIZATION'S 990 FILINGS. ULTIMATELY, A NEW CONTRACT IS PRESENTED TO THE BOARD FOR APPROVAL THAT OUTLINES COMPENSATION AND PERFORMANCE EXPECTATIONS. IN NON-CONTRACT RENEWAL YEARS, THE SUBCOMMITTEE COMPLETES A DRAFT ANNUAL PERFORMANCE REVIEW FOR THE BOARD'S CONSIDERATION PRIOR TO CONDUCTING THE ANNUAL PERFORMANCE REVIEW ALONG WITH A SET OF CEO PERFORMANCE OBJECTIVES FOR THE UPCOMING YEAR AND A CEO SELF-ASSESSMENT SUMMARY. IN ALL CASES CEO PERFORMANCE IS MEASURED AGAINST BOARD-APPROVED ANNUAL PERFORMANCE OBJECTIVES. OTHER OFFICERS OR KEY EMPLOYEES: THE CEO DETERMINES COMPENSATION FOR KEY EMPLOYEES RELYING HEAVILY UPON THE GUIDANCE OF THE HUMAN RESOURCES DEPARTMENT OF ASHP. ASAE SURVEY DATA IS REVIEWED WHEN COMPARABLE POSITIONS EXIST FOR THE KEY EMPLOYEE POSITION (E.G. DIRECTOR OF COMMUNICATIONS). THE HUMAN RESOURCES DEPARTMENT UTILIZES ADDITIONAL SALARY SURVEY DATABASES TO COMPARE SALARIES. FOR POSITIONS WHERE A PHARMACIST IS A JOB REQUIREMENT, PHARMACIST POSITIONS IN HOSPITALS AND HEALTH-SYSTEMS THAT WOULD BE LIKELY CANDIDATE POOLS ARE QUERIED IN THE SALARY SURVEY DATABASES. ADDITIONALLY, THE HR DEPARTMENT CAN PROVIDE COMPARATIVE DATA FOR PHARMACIST POSITIONS AT ASHP. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE FOUNDATION'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. |
| FORM 990, PART IX, LINE 11G | CONTRACT SERVICES: PROGRAM SERVICE EXPENSES 314,350. MANAGEMENT AND GENERAL EXPENSES 75,953. FUNDRAISING EXPENSES 30,131. TOTAL EXPENSES 420,434. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP) | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4500 EAST-WEST HIGHWAY SUITE 900 | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 520807628 | EIN |
| Primary Activities | TO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSION | PrimaryActivitiesTxt |
| Legal Domicile State | MD | LegalDomicileStateCd |
| Exempt Code Section | 501(C)(6) | ExemptCodeSectionTxt |
| Direct Controlling NA | N/A | DirectControllingNACd |
| Controlled Organization | 0 | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | Yes (1) | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (1) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (1) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (1) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (1) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | 0 | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | Yes (1) | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (5 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| C | $357,100 | CASH |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| N | $509,291 | RECORDED EXPENSES |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| O | $180,698 | FAIR VALUE |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| P | $1,704,011 | RECORDED EXPENSES |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| S | $1,194,721 | CASH |
Comments